154 related articles for article (PubMed ID: 29661533)
21. Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases.
Richter SN; Giaretta G; Comuzzi V; Leo E; Mitchenall LA; Fisher LM; Maxwell A; Palumbo M
Nucleic Acids Res; 2007; 35(18):6075-85. PubMed ID: 17766248
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel oxoindolin derivatives as atypical dual inhibitors for DNA Gyrase and FabH.
Yang YS; Su MM; Xu JF; Liu QX; Bai LF; Hu XW; Zhu HL
Bioorg Chem; 2019 Dec; 93():103309. PubMed ID: 31585266
[TBL] [Abstract][Full Text] [Related]
23. Molecular Modeling Studies of Novel Fluoroquinolone Molecules.
Allaka TR; Katari NK; Veeramreddy V; Anireddy JS
Curr Drug Discov Technol; 2018; 15(2):109-122. PubMed ID: 28875852
[TBL] [Abstract][Full Text] [Related]
24. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
Sriram D; Aubry A; Yogeeswari P; Fisher LM
Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
[TBL] [Abstract][Full Text] [Related]
25. Identification of secondary metabolites from Crescentia cujete as promising antibacterial therapeutics targeting type 2A topoisomerases through molecular dynamics simulation.
Aribisala JO; Abdulsalam RA; Dweba Y; Madonsela K; Sabiu S
Comput Biol Med; 2022 Jun; 145():105432. PubMed ID: 35344868
[TBL] [Abstract][Full Text] [Related]
26. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
Fernandez-Moreira E; Balas D; Gonzalez I; de la Campa AG
Microb Drug Resist; 2000; 6(4):259-67. PubMed ID: 11272253
[TBL] [Abstract][Full Text] [Related]
27. DNA gyrase with a single catalytic tyrosine can catalyze DNA supercoiling by a nicking-closing mechanism.
Gubaev A; Weidlich D; Klostermeier D
Nucleic Acids Res; 2016 Dec; 44(21):10354-10366. PubMed ID: 27557712
[TBL] [Abstract][Full Text] [Related]
28. Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site.
Franco-Ulloa S; La Sala G; Miscione GP; De Vivo M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401640
[TBL] [Abstract][Full Text] [Related]
29. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
[TBL] [Abstract][Full Text] [Related]
30. Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism.
Nöllmann M; Crisona NJ; Arimondo PB
Biochimie; 2007 Apr; 89(4):490-9. PubMed ID: 17397985
[TBL] [Abstract][Full Text] [Related]
31. Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
Skepper CK; Armstrong D; Balibar CJ; Bauer D; Bellamacina C; Benton BM; Bussiere D; De Pascale G; De Vicente J; Dean CR; Dhumale B; Fisher LM; Fuller J; Fulsunder M; Holder LM; Hu C; Kantariya B; Lapointe G; Leeds JA; Li X; Lu P; Lvov A; Ma S; Madhavan S; Malekar S; McKenney D; Mergo W; Metzger L; Moser HE; Mutnick D; Noeske J; Osborne C; Patel A; Patel D; Patel T; Prajapati K; Prosen KR; Reck F; Richie DL; Rico A; Sanderson MR; Satasia S; Sawyer WS; Selvarajah J; Shah N; Shanghavi K; Shu W; Thompson KV; Traebert M; Vala A; Vala L; Veselkov DA; Vo J; Wang M; Widya M; Williams SL; Xu Y; Yue Q; Zang R; Zhou B; Rivkin A
J Med Chem; 2020 Jul; 63(14):7773-7816. PubMed ID: 32634310
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.
Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
J Biomol Struct Dyn; 2018 Feb; 36(2):362-375. PubMed ID: 28071975
[TBL] [Abstract][Full Text] [Related]
33. YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyrase.
Sengupta S; Nagaraja V
Nucleic Acids Res; 2008 Aug; 36(13):4310-6. PubMed ID: 18586829
[TBL] [Abstract][Full Text] [Related]
34. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
Minovski N; Perdih A; Novic M; Solmajer T
J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
[TBL] [Abstract][Full Text] [Related]
35. Why Two? On the Role of (A-)Symmetry in Negative Supercoiling of DNA by Gyrase.
Klostermeier D
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772727
[TBL] [Abstract][Full Text] [Related]
36. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
[TBL] [Abstract][Full Text] [Related]
37. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
38. DNA gyrase-mediated wrapping of the DNA strand is required for the replication fork arrest by the DNA gyrase-quinolone-DNA ternary complex.
Hiasa H; Shea ME
J Biol Chem; 2000 Nov; 275(44):34780-6. PubMed ID: 11053451
[TBL] [Abstract][Full Text] [Related]
39. Basic residues at the C-gate of DNA gyrase are involved in DNA supercoiling.
Smith EM; Mondragón A
J Biol Chem; 2021 Aug; 297(2):101000. PubMed ID: 34303706
[TBL] [Abstract][Full Text] [Related]
40. The mechanism of negative DNA supercoiling: a cascade of DNA-induced conformational changes prepares gyrase for strand passage.
Gubaev A; Klostermeier D
DNA Repair (Amst); 2014 Apr; 16():23-34. PubMed ID: 24674625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
